Overview

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Status:
Recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET and Ga-68-DOTATOC PET in patients with meningioma.
Phase:
Phase 2
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
Cornell University
Treatments:
Edotreotide
Octreotide